IBD: Optimized Infliximab Monotherapy vs Combination Therapy IBD: Optimized Infliximab Monotherapy vs Combination Therapy
This study compared the clinical efficacy and cost of two different IBD treatment strategies for the introduction of infliximab: 6-12 months in combination with azathioprine versus optimized monotherapy.Alimentary Pharmacology & Therapeutics
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Gastroenterology Journal Article Source Type: news
More News: Allergy | Allergy & Immunology | Drugs & Pharmacology | Gastroenterology | Remicade | Study